{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:59:21Z","timestamp":1788256761459,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T00:00:00Z","timestamp":1447372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T00:00:00Z","timestamp":1447372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/cgt.2015.59","type":"journal-article","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T11:21:53Z","timestamp":1447413713000},"page":"13-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Synergistic tumor suppression by adenovirus-mediated ING4\/PTEN double gene therapy for gastric cancer"],"prefix":"10.1038","volume":"23","author":[{"given":"H","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,13]]},"reference":[{"key":"BFcgt201559_CR1","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1016\/j.febslet.2014.03.011","volume":"588","author":"G Tallen","year":"2014","unstructured":"Tallen G, Riabowol K . Keep-ING balance: tumor suppression by epigenetic regulation. FEBS Lett 2014; 588: 2728\u20132742.","journal-title":"FEBS Lett"},{"key":"BFcgt201559_CR2","first-page":"2373","volume":"63","author":"M Shiseki","year":"2003","unstructured":"Shiseki M, Nagashima M, Pedeux RM, Kitahama-Shiseki M, Miura K, Okamura S et al. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res 2003; 63: 2373\u20132378.","journal-title":"Cancer Res"},{"key":"BFcgt201559_CR3","doi-asserted-by":"publisher","first-page":"34677","DOI":"10.1074\/jbc.M606296200","volume":"281","author":"M Unoki","year":"2006","unstructured":"Unoki M, Shen JC, Zheng ZM, Harris CC . Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility. J Biol Chem 2006; 281: 34677\u201334686.","journal-title":"J Biol Chem"},{"key":"BFcgt201559_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.canlet.2008.05.050","volume":"271","author":"Y Xie","year":"2008","unstructured":"Xie Y, Zhang H, Sheng W, Xiang J, Ye Z, Yang J . Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis. Cancer Lett 2008; 271: 105\u2013116.","journal-title":"Cancer Lett"},{"key":"BFcgt201559_CR5","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.yexcr.2013.05.004","volume":"319","author":"A Gong","year":"2013","unstructured":"Gong A, Ye S, Xiong E, Guo W, Zhang Y, Peng W et al. Autophagy contributes to ING4-induced glioma cell death. Exp Cell Res 2013; 319: 1714\u20131723.","journal-title":"Exp Cell Res"},{"key":"BFcgt201559_CR6","doi-asserted-by":"publisher","first-page":"16251","DOI":"10.1073\/pnas.0407158101","volume":"101","author":"S Kim","year":"2004","unstructured":"Kim S, Chin K, Gray JW, Bishop JM . A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc Natl Acad Sci USA 2004; 101: 16251\u201316256.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201559_CR7","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1158\/0008-5472.CAN-06-3870","volume":"67","author":"JC Shen","year":"2007","unstructured":"Shen JC, Unoki M, Ythier D, Duperray A, Varticovski L, Kumamoto K et al. Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1. Cancer Res 2007; 67: 2552\u20132558.","journal-title":"Cancer Res"},{"key":"BFcgt201559_CR8","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/carcin\/bgn086","volume":"29","author":"J Li","year":"2008","unstructured":"Li J, Martinka M, Li G . Role of ING4 in human melanoma cell migration, invasion and patient survival. Carcinogenesis 2008; 29: 1373\u20131379.","journal-title":"Carcinogenesis"},{"key":"BFcgt201559_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature02329","volume":"428","author":"I Garkavtsev","year":"2004","unstructured":"Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E et al. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 2004; 428: 328\u2013332.","journal-title":"Nature"},{"key":"BFcgt201559_CR10","doi-asserted-by":"publisher","first-page":"6632","DOI":"10.1128\/MCB.00697-08","volume":"28","author":"S Nozell","year":"2008","unstructured":"Nozell S, Laver T, Moseley D, Nowoslawski L, De Vos M, Atkinson GP et al. The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes. Mol Cell Biol 2008; 28: 6632\u20136645.","journal-title":"Mol Cell Biol"},{"key":"BFcgt201559_CR11","doi-asserted-by":"publisher","first-page":"7481","DOI":"10.1073\/pnas.0502716102","volume":"102","author":"A Ozer","year":"2005","unstructured":"Ozer A, Wu LC, Bruick RK . The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proc Natl Acad Sci USA 2005; 102: 7481\u20137486.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201559_CR12","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1182\/blood-2007-02-074617","volume":"110","author":"S Colla","year":"2007","unstructured":"Colla S, Tagliaferri S, Morandi F, Lunghi P, Donofrio G, Martorana D et al. The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis. Blood 2007; 110: 4464\u20134475.","journal-title":"Blood"},{"key":"BFcgt201559_CR13","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1038\/onc.2013.135","volume":"33","author":"Y Hou","year":"2013","unstructured":"Hou Y, Zhang Z, Xu Q, Wang H, Xu Y, Chen K . Inhibitor of growth 4 induces NFkappaB\/p65 ubiquitin-dependent degradation. Oncogene 2013; 33: 1997\u20132003.","journal-title":"Oncogene"},{"key":"BFcgt201559_CR14","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.febslet.2013.04.004","volume":"587","author":"M Lu","year":"2013","unstructured":"Lu M, Pan C, Zhang L, Ding C, Chen F, Wang Q et al. ING4 inhibits the translation of proto-oncogene MYC by interacting with AUF1. FEBS Lett 2013; 587: 1597\u20131604.","journal-title":"FEBS Lett"},{"key":"BFcgt201559_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrm3330","volume":"13","author":"MS Song","year":"2012","unstructured":"Song MS, Salmena L, Pandolfi PP . The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 2012; 13: 283\u2013296.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcgt201559_CR16","doi-asserted-by":"publisher","first-page":"15406","DOI":"10.1073\/pnas.95.26.15406","volume":"95","author":"DM Li","year":"1998","unstructured":"Li DM, Sun H . PTEN\/MMAC1\/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci U S A 1998; 95: 15406\u201315411.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFcgt201559_CR17","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1038\/sj.gt.3302100","volume":"10","author":"Y Saito","year":"2003","unstructured":"Saito Y, Swanson X, Mhashilkar AM, Oida Y, Schrock R, Branch CD et al. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo. Gene Ther 2003; 10: 1961\u20131969.","journal-title":"Gene Ther"},{"key":"BFcgt201559_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/sj.cgt.7701116","volume":"15","author":"H Jin","year":"2008","unstructured":"Jin H, Xu CX, Kim HW, Chung YS, Shin JY, Chang SH et al. Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-ras(LA1) mice. Cancer Gene Ther 2008; 15: 275\u2013283.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201559_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cell.2012.02.030","volume":"149","author":"I Garcia-Cao","year":"2012","unstructured":"Garcia-Cao I, Song MS, Hobbs RM, Laurent G, Giorgi C, de Boer VC et al. Systemic elevation of PTEN induces a tumor-suppressive metabolic state. Cell 2012; 149: 49\u201362.","journal-title":"Cell"},{"key":"BFcgt201559_CR20","first-page":"442","volume":"59","author":"M Tamura","year":"1999","unstructured":"Tamura M, Gu J, Takino T, Yamada KM . Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. Cancer Res 1999; 59: 442\u2013449.","journal-title":"Cancer Res"},{"key":"BFcgt201559_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cellsig.2014.01.025","volume":"26","author":"LL Zhang","year":"2014","unstructured":"Zhang LL, Liu J, Lei S, Zhang J, Zhou W, Yu HG . PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression. Cell Signal 2014; 26: 1011\u20131020.","journal-title":"Cell Signal"},{"key":"BFcgt201559_CR22","first-page":"823","volume":"38","author":"E Schneider","year":"2011","unstructured":"Schneider E, Keppler R, Prawitt D, Steinwender C, Roos FC, Thuroff JW et al. Migration of renal tumor cells depends on dephosphorylation of Shc by PTEN. Int J Oncol 2011; 38: 823\u2013831.","journal-title":"Int J Oncol"},{"key":"BFcgt201559_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/1541-7786.MCR-10-0235","volume":"9","author":"MA Chetram","year":"2011","unstructured":"Chetram MA, Odero-Marah V, Hinton CV . Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1\/2 in prostate cancer cells. Mol Cancer Res 2011; 9: 90\u2013102.","journal-title":"Mol Cancer Res"},{"key":"BFcgt201559_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0304-3835(01)00632-2","volume":"172","author":"PH Hwang","year":"2001","unstructured":"Hwang PH, Yi HK, Kim DS, Nam SY, Kim JS, Lee DY . Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN\/MMAC1\/TEP1 gene. Cancer Lett 2001; 172: 83\u201391.","journal-title":"Cancer Lett"},{"key":"BFcgt201559_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cell.2010.12.020","volume":"144","author":"MS Song","year":"2011","unstructured":"Song MS, Carracedo A, Salmena L, Song SJ, Egia A, Malumbres M et al. Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell 2011; 144: 187\u2013199.","journal-title":"Cell"},{"key":"BFcgt201559_CR26","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/nature08486","volume":"461","author":"AJ Trimboli","year":"2009","unstructured":"Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, Creasap N et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 2009; 461: 1084\u20131091.","journal-title":"Nature"},{"key":"BFcgt201559_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1126\/science.1234907","volume":"341","author":"BD Hopkins","year":"2013","unstructured":"Hopkins BD, Fine B, Steinbach N, Dendy M, Rapp Z, Shaw J et al. A secreted PTEN phosphatase that enters cells to alter signaling and survival. Science 2013; 341: 399\u2013402.","journal-title":"Science"},{"key":"BFcgt201559_CR28","doi-asserted-by":"publisher","first-page":"ra70","DOI":"10.1126\/scisignal.2003084","volume":"5","author":"U Putz","year":"2012","unstructured":"Putz U, Howitt J, Doan A, Goh CP, Low LH, Silke J et al. The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells. Sci Signal 2012; 5: ra70.","journal-title":"Sci Signal"},{"key":"BFcgt201559_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin 2011; 61: 69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"BFcgt201559_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2174\/1389201023378445","volume":"3","author":"DR Wilson","year":"2002","unstructured":"Wilson DR . Viral-mediated gene transfer for cancer treatment. Curr Pharm Biotechnol 2002; 3: 151\u2013164.","journal-title":"Curr Pharm Biotechnol"},{"key":"BFcgt201559_CR31","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1016\/S1470-2045(13)70173-6","volume":"14","author":"MK Brenner","year":"2013","unstructured":"Brenner MK, Gottschalk S, Leen AM, Vera JF . Is cancer gene therapy an empty suit? Lancet Oncol 2013; 14: e447\u2013e456.","journal-title":"Lancet Oncol"},{"key":"BFcgt201559_CR32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1089\/cbr.2011.1047","volume":"26","author":"Y Xie","year":"2011","unstructured":"Xie Y, Lv H, Sheng W, Miao J, Xiang J, Yang J . Synergistic tumor suppression by adenovirus-mediated inhibitor of growth 4 and interleukin-24 gene cotransfer in hepatocarcinoma cells. Cancer Biother Radiopharm 2011; 26: 681\u2013695.","journal-title":"Cancer Biother Radiopharm"},{"key":"BFcgt201559_CR33","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/cgt.2011.31","volume":"18","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Lv H, Xie Y, Sheng W, Xiang J, Yang J . Enhanced tumor suppression by an ING4\/IL-24 bicistronic adenovirus-mediated gene cotransfer in human non-small cell lung cancer cells. Cancer Gene Ther 2011; 18: 627\u2013636.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201559_CR34","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/ijc.10962","volume":"104","author":"DS Byun","year":"2003","unstructured":"Byun DS, Cho K, Ryu BK, Lee MG, Park JI, Chae KS et al. Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma. Int J Cancer 2003; 104: 318\u2013327.","journal-title":"Int J Cancer"},{"key":"BFcgt201559_CR35","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1089\/1043034041361181","volume":"15","author":"Y Liu","year":"2004","unstructured":"Liu Y, Ye T, Sun D, Maynard J, Deisseroth A . Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma. Hum Gene Ther 2004; 15: 637\u2013647.","journal-title":"Hum Gene Ther"},{"key":"BFcgt201559_CR36","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","volume":"95","author":"TC He","year":"1998","unstructured":"He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B . A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509\u20132514.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201559_CR37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF00666038","volume":"36","author":"N Weidner","year":"1995","unstructured":"Weidner N . Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995; 36: 169\u2013180.","journal-title":"Breast Cancer Res Treat"},{"key":"BFcgt201559_CR38","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3748\/wjg.v7.i5.702","volume":"7","author":"W Wang","year":"2001","unstructured":"Wang W, Qin SK, Chen BA, Chen HY . Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma. World J Gastroenterol 2001; 7: 702\u2013705.","journal-title":"World J Gastroenterol"},{"key":"BFcgt201559_CR39","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbrc.2010.04.005","volume":"395","author":"X Zhang","year":"2010","unstructured":"Zhang X, Zhu W, Zhang J, Huo S, Zhou L, Gu Z et al. MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity. Biochem Biophys Res Commun 2010; 395: 275\u2013280.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcgt201559_CR40","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1093\/emboj\/17.11.3005","volume":"17","author":"HE Ryan","year":"1998","unstructured":"Ryan HE, Lo J, Johnson RS . HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 1998; 17: 3005\u20133015.","journal-title":"EMBO J"},{"key":"BFcgt201559_CR41","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nrc909","volume":"2","author":"N Ferrara","year":"2002","unstructured":"Ferrara N . VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2002; 2: 795\u2013803.","journal-title":"Nat Rev Cancer"},{"key":"BFcgt201559_CR42","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C et al. Mutational landscape and significance across 12 major cancer types. Nature 2013; 502: 333\u2013339.","journal-title":"Nature"},{"key":"BFcgt201559_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrclinonc.2010.174","volume":"8","author":"CF Cheok","year":"2011","unstructured":"Cheok CF, Verma CS, Baselga J, Lane DP . Translating p53 into the clinic. Nat Rev Clin Oncol 2011; 8: 25\u201337.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFcgt201559_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1535-6108(03)00021-7","volume":"3","author":"DJ Freeman","year":"2003","unstructured":"Freeman DJ, Li AG, Wei G, Li HH, Kertesz N, Lesche R et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 2003; 3: 117\u2013130.","journal-title":"Cancer Cell"},{"key":"BFcgt201559_CR45","doi-asserted-by":"publisher","first-page":"11598","DOI":"10.1073\/pnas.181181198","volume":"98","author":"LD Mayo","year":"2001","unstructured":"Mayo LD, Donner DB . A phosphatidylinositol 3-kinase\/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci U S A 2001; 98: 11598\u201311603.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFcgt201559_CR46","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/ncb1101-973","volume":"3","author":"BP Zhou","year":"2001","unstructured":"Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC . HER-2\/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 2001; 3: 973\u2013982.","journal-title":"Nat Cell Biol"},{"key":"BFcgt201559_CR47","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.molcel.2006.06.028","volume":"23","author":"AG Li","year":"2006","unstructured":"Li AG, Piluso LG, Cai X, Wei G, Sellers WR, Liu X . Mechanistic insights into maintenance of high p53 acetylation by PTEN. Mol Cell 2006; 23: 575\u2013587.","journal-title":"Mol Cell"},{"key":"BFcgt201559_CR48","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.bbrc.2005.04.023","volume":"331","author":"X Zhang","year":"2005","unstructured":"Zhang X, Wang KS, Wang ZQ, Xu LS, Wang QW, Chen F et al. Nuclear localization signal of ING4 plays a key role in its binding to p53. Biochem Biophys Res Commun 2005; 331: 1032\u20131038.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcgt201559_CR49","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646\u2013674.","journal-title":"Cell"},{"key":"BFcgt201559_CR50","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1172\/JCI70212","volume":"123","author":"J Welti","year":"2013","unstructured":"Welti J, Loges S, Dimmeler S, Carmeliet P . Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest 2013; 123: 3190\u20133200.","journal-title":"J Clin Invest"},{"key":"BFcgt201559_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11684-012-0176-8","volume":"6","author":"B Shang","year":"2012","unstructured":"Shang B, Cao Z, Zhou Q . Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives. Front Med 2012; 6: 67\u201378.","journal-title":"Front Med"},{"key":"BFcgt201559_CR52","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1073\/pnas.081063798","volume":"98","author":"S Wen","year":"2001","unstructured":"Wen S, Stolarov J, Myers MP, Su JD, Wigler MH, Tonks NK et al. PTEN controls tumor-induced angiogenesis. Proc Natl Acad Sci USA 2001; 98: 4622\u20134627.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201559_CR53","first-page":"363","volume":"12","author":"BH Jiang","year":"2001","unstructured":"Jiang BH, Jiang G, Zheng JZ, Lu Z, Hunter T, Vogt PK . Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ 2001; 12: 363\u2013369.","journal-title":"Cell Growth Differ"},{"key":"BFcgt201559_CR54","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1128\/MCB.21.12.3995-4004.2001","volume":"21","author":"E Laughner","year":"2001","unstructured":"Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL . HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001; 21: 3995\u20134004.","journal-title":"Mol Cell Biol"},{"key":"BFcgt201559_CR55","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1101\/gad.14.4.391","volume":"14","author":"W Zundel","year":"2000","unstructured":"Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, Chen E et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 2000; 14: 391\u2013396.","journal-title":"Genes Dev"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201559.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201559","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201559.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T12:03:11Z","timestamp":1647950591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,13]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["BFcgt201559"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2015.59","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,13]]},"assertion":[{"value":"11 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}